C. Harris

发表

p53 protein accumulates frequently in early bronchial neoplasia.

R. Metcalf, J. Samet, Y. Takeshima, 1993, Cancer research.

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

C. Harris, M. Hollstein, M. Greenblatt, 1994, Cancer research.

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer

E. Bowman, S. Ambs, A. Robles, 2012, International journal of cancer.

Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer

Julie Goodman, Meredith Yeager, Krista A. Zanetti, 2014, International journal of cancer.

GADD45 induction of a G2/M cell cycle checkpoint.

C. Harris, P. O'Connor, A. Fornace, 1999, Proceedings of the National Academy of Sciences of the United States of America.

The IARC TP53 database: New online mutation analysis and recommendations to users

C. Harris, M. Olivier, R. Eeles, 2002, Human mutation.

Growth and differentiation of normal and transformed human bronchial epithelial cells

J. Willey, C. Harris, T. Masui, 1986, Journal of cellular physiology. Supplement.

Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma

E. Bowman, M. Kohonen-Corish, W. Cooper, 2022, Genome Medicine.

Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.

C. Harris, J. Rhim, R. Reddel, 1988, Cancer research.

Cancer risk and low-penetrance susceptibility genes in gene-environment interactions.

C. Harris, P. Shields, C. Harris, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular epidemiology and the genetics of environmental cancer.

C. Harris, P. Shields, P G Shields, 1991, JAMA.

Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population

D. Butkiewicz, M. Chorąży, M. Rusin, 2000, Human mutation.

Reproductive and hormonal factors and the risk of nonsmall cell lung cancer

E. Bowman, A. Berrington de González, J. Lacey, 2011, International journal of cancer.

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

X. Wang, C. Deng, C. Harris, 1999, Molecular cell.

Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.

C. Harris, S. Ambs, P. Shields, 1998, Cancer research.

Novel genetic polymorphisms in DNA repair genes: O6‐methylguanine‐DNA methyltransferase (MGMT) and N‐methylpurine‐DNA glycosylase (MPG) in lung cancer patients from Poland

M. Chorąży, A. Samojedny, M. Rusin, 1999, Human mutation.

p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

R. Metcalf, E. Appella, J. Testa, 1991, Cancer research.

Clonal growth of epithelial cells from normal adult human bronchus.

C. Harris, B. Trump, A. Haugen, 1981, Cancer research.

Interactive effects of nitric oxide and the p 53 tumor suppressor gene in carcinogenesis and tumor progression

C. Harris, S. Ambs, Stefan, 2004 .

The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation.

Leah E. Mechanic, V. Rotter, C. Harris, 2003, The Journal of clinical investigation.

Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.

K Raja, J A Swenberg, W P Bennett, 2000, Cancer research.

Nitric oxide and p53 in cancer‐prone chronic inflammation and oxyradical overload disease

S. Hussain, L. Hofseth, J. Goodman, 2004, Environmental and molecular mutagenesis.

Genetic reduction of circulating insulin‐like growth factor‐1 inhibits azoxymethane‐induced colon tumorigenesis in mice

S. Yakar, S. Perkins, S. Hursting, 2006, Molecular carcinogenesis.

Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.

C. Harris, Mohammed A. Khan, S. Ambs, 1998, British Journal of Cancer.

Molecular epidemiology of human cancer risk: gene–environment interactions and p53 mutation spectrum in human lung cancer

W P Bennett, Mohammed A. Khan, P. Shields, 1999, The Journal of pathology.

Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer

A. Schetter, E. Bowman, C. Harris, 2012, International journal of cancer.

Cooperation of tumor‐derived HBx mutants and p53‐249ser mutant in regulating cell proliferation, anchorage‐independent growth and aneuploidy in a telomerase‐immortalized normal human hepatocyte‐derived cell line

X. Wang, E. Bowman, T. Unger, 2009, International journal of cancer.

Molecular pathogenesis of human hepatocellular carcinoma.

X. Wang, C. Harris, M. Forgues, 2002, Toxicology.

Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.

C. Harris, S. Hussain, C. Harris, 2000, Mutation research.

Cellular Stress Induced Alterations in MicroRNA let-7a and let-7b Expression Are Dependent on p53

James B. Mitchell, N. Simone, Anthony D. Saleh, 2011, PloS one.

COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective

C. Harris, C. Harris, 1996 .

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

R. Metcalf, C. Harris, W. Bennett, 1993, Carcinogenesis.

p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective.

C. Harris, 1996, Carcinogenesis.

Nitric Oxide, a Mediator of Inflammation, Suppresses Tumorigenesis

Leah E. Mechanic, C. Harris, S. Hussain, 2004, Cancer Research.

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.

C. Harris, K. Forrester, X. W. Wang, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Somatic allelic deletion of nm23 in human cancer.

L. Liotta, R. Rees, W. Linehan, 1991, Cancer research.

Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.

C. Harris, R. Stahel, R. Reddel, 1989, The American journal of pathology.

Genetic polymorphisms in DNA repair genes and risk of lung cancer.

C. Harris, P. Shields, L. Enewold, 2001, Carcinogenesis.

Patterns of second malignant neoplasms in children

A. Meadows, G. D'angio, R. Jenkin, 1977, Cancer.

Articles activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2

C. Harris, A. Pfeifer, R. C. Garner, 1994, Molecular carcinogenesis.

Microbiome-TP53 Gene Interaction in Human Lung Cancer

Archana S Bhat, Sergey V. Balashov, Julia Oh, 2018, bioRxiv.

UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML

E. Bowman, K. Borden, J. Milner, 2003, Oncogene.

Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.

A. Newton, Xiang-Dong Fu, Huilin Zhou, 2014, Molecular cell.

NOS2 enhances KRAS‐induced lung carcinogenesis, inflammation and microRNA‐21 expression

J. Weiss, S. Hussain, J. Stauffer, 2013, International journal of cancer.

Carcinogenesis in mouse and human cells: parallels and paradoxes.

A. Balmain, C. Harris, C C Harris, 2000, Carcinogenesis.

ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression

N. Yanaihara, E. Bowman, K. Kumamoto, 2009, International journal of cancer.

Reviewing the current classification of inhibitor of growth family proteins

K. Kumamoto, S. Takenoshita, M. Unoki, 2009, Cancer science.

Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease

Jane J. Sohn, A. Schetter, E. Bowman, 2012, PloS one.

Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer

T. Ohno, T. Oike, Y. Yoshimoto, 2023, Heliyon.

Matrin3 regulates cell proliferation and spindle dynamics by regulating CDC14B alternative splicing

M. Aladjem, A. Lal, X. L. Li, 2022, bioRxiv.

Perspective: Cell Differentiation Theory May Advance Early Detection of and Therapy for Lung Cancer

H. Pass, S. Belinsky, J. Lechner, 2001, Radiation research.

Polycyclic aromatic hydrocarbon-DNA adducts and the CYP1A1 restriction fragment length polymorphism.

E. Bowman, C. Harris, P. Shields, 1992, Environmental health perspectives.

p53 and K-ras mutations in lung cancers from former and never-smoking women.

C. Harris, Mohammed A. Khan, M. A. Khan, 2001, Cancer research.

Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

P. Steeg, D. Roberts, V. Zabrenetzky, 1994, International journal of cancer.

Clinical implications of the p53 tumor-suppressor gene.

M. Hollstein, C. Harris, C. Harris, 1993, The New England journal of medicine.

Mutational spectrum of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

C. Harris, M. Greenblatt, W. Bennett, 1994, Drug metabolism reviews.

Clonal variation of tumorigenic potential in v‐Ha‐ras‐transformed human bronchial epithelial cells: Relationship to ras oncogene expression and CAD gene amplification

T. Tlsty, K. Forrester, B. Gerwin, 1994, Molecular carcinogenesis.

Serum, plasma and paraffin-embedded tissues as sources of DNA for studying cancer susceptibility genes.

C. Harris, P. Shields, W. Bennett, 1997, Carcinogenesis.

p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers.

C. Harris, M. Hollstein, M. Marion, 1994, Carcinogenesis.

Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women.

E. Bowman, C. Harris, Mohammed A. Khan, 1999, Journal of the National Cancer Institute.

Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes.

C. Harris, S. Hussain, C. Harris, 1998, Cancer research.

Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral harvey ras

C. Harris, A. Pfeifer, R. Reddel, 1988, Molecular carcinogenesis.

Molecular epidemiology of human cancer.

C. Harris, S. Hussain, S P Hussain, 1998, Toxicology letters.

Combined high-performance liquid chromatography/32P-postlabeling assay of N7-methyldeoxyguanosine.

V. L. Wilson, C. Harris, V. Wilson, 1990, Cancer research.

Environmental causes of cancer.

C. Harris, P. Shields, C. Harris, 1990, The Medical clinics of North America.

Determination of polycyclic aromatic hydrocarbons in the urine, benzo(a)pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere.

C. Harris, A. Haugen, K. Vähäkangas, 1986, Cancer research.

Differences in Metabolism of Chemical Carcinogens in Cultured Human Epithelial Tissues and Cells

C. Harris, B. Trump, H. Autrup, 1982, Journal of cellular biochemistry.

Chemical and physical carcinogenesis: advances and perspectives for the 1990s.

C. Harris, C. Harris, C. Harris, 1991, Cancer research.

FHIT mutations in human primary gastric cancer.

C. Harris, Mohammed A. Khan, M. A. Khan, 1997, Cancer research.

Oncogenes and tumor-suppressor genes.

C. Harris, R. Reddel, T. Lehman, 1991, Environmental health perspectives.

Melanoma-intrinsic NR2F6 activity regulates antitumor immunity

E. Ruppin, R. Sears, M. Herlyn, 2023, Science advances.

Serum alpha1‐antitrypsin in patients with lung cancer or abnormal sputum cytology

C. Harris, G. Saccomanno, A. Primack, 1976, Cancer.

Elevated alpha1‐antitrypsin serum levels in lung cancer patients

A. Primack, M. Cohen, C. Harris, 1974, Cancer.

Quantitative Image Analysis of p53 Protein Accumulation in Keratoacanthomas

R. T. Jones, A. Borkowski, C. Harris, 1995, The American Journal of dermatopathology.

An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.

C. Harris, W. Bennett, Y. Soini, 1996, Carcinogenesis.

Geographic variation of p53 mutational profile in nonmalignant human liver.

C. Harris, P. Cerutti, M. Hollstein, 1994, Science.

p53 Tumor Suppressor Gene: At the Crossroads of Molecular Carcinogenesis, Molecular Epidemiology, and Human Risk Assessment

S. Hussain, C. Harris, MONICA H. HOLLSTEIN, 2000, Annals of the New York Academy of Sciences.

Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.

C. Harris, X. W. Wang, L. Elmore, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features

Wojciech Makalowski, M. Boguski, C. Harris, 1999, Oncogene.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.

R. E. Luna, F. Galateau-Sallé, L. Liotta, 2000, Human pathology.

Restriction fragment length polymorphism analysis of the l‐myc gene locus in a case‐control study of lung cancer

J. Resau, B. Trump, H. Sugimura, 1990, International journal of cancer.

p53: at the crossroads of molecular carcinogenesis and risk assessment.

C. Harris, C C Harris, C. Harris, 1993, Science.

Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO)

C. Harris, D. Consonni, A. Andrew, 2013, British Journal of Cancer.

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.

J. Jett, W. Travis, P. Pairolero, 1995, Carcinogenesis.

microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma

A. Schetter, X. Wang, Y. Ke, 2013, International journal of cancer.

p53 tumor suppressor gene: implications for iatrogenic cancer and cancer therapy.

M. Greenblatt, W. Bennett, V. D. Benedetti, 1996, Medical and pediatric oncology. Supplement.

High miR‐21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer

E. Bowman, Mohammed A. Khan, M. Okajima, 2014, International journal of cancer.

The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.

John N Weinstein, Frank Staib, X. Wang, 2005, Cancer research.

Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride.

C. Harris, M. Hollstein, M. Marion, 1995, Journal of the National Cancer Institute.

Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case‐control study

Leah E. Mechanic, Ourania Kosti, E. Bowman, 2010, International journal of cancer.

Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer

A. Yoshimura, A. Gemma, M. Seike, 2000, Genes, chromosomes & cancer.

Quantitative detection of p53 mutations in plasma DNA from tobacco smokers.

Leah E. Mechanic, E. Bowman, K. Kumamoto, 2006, Cancer research.

Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China

S. Thorgeirsson, M. Gail, Zong-tang Sun, 2002, Hepatology.

Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation.

C. Harris, J. Rhim, R. Reddel, 1988, Oncogene research.

A Two‐Gene Prognostic Classifier for Early‐Stage Lung Squamous Cell Carcinoma in Multiple Large‐Scale and Geographically Diverse Cohorts

A. Gemma, M. Seike, E. Bowman, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma

Y. Pomyen, C. Loffredo, C. Pairojkul, 2023, Scientific reports.

Bile salt hydrolase in non-enterotoxigenic Bacteroides potentiates colorectal cancer

Y. Zhang, Jiong Cai, A. Patterson, 2023, Nature Communications.

BLM helicase‐dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination

J. Shay, K. Valerie, B. Wasylyk, 2003, The EMBO journal.

Differential effects of p53 mutants on the growth of human bronchial epithelial cells

C. Harris, Mohammed A. Khan, J. Pietenpol, 1997, Molecular carcinogenesis.

The role of microRNA in nutritional control

D. Baltimore, E. van Rooij, E. N. Nolte-‘t Hoen, 2015, Journal of internal medicine.

DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53

X. Wang, J. Yokota, S. Linke, 2001, Proceedings of the National Academy of Sciences of the United States of America.

APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.

C. Harris, A. Robles, N. A. Bemmels, 2001, Cancer research.